Peripheral O
oxytocin O
and O
vasopressin O
modulates O
regional O
brain O
activity O
differently O
in O
men O
and O
women O
with O
schizophrenia O
Background O
Oxytocin O
( O
OT O
) O
and O
arginine O
vasopressin O
( O
AVP O
) O
exert O
sexually O
dimorphic O
effects O
on O
cognition O
and O
emotion O
processing O
. O

Abnormalities O
in O
these O
hormones O
are O
observed O
in O
schizophrenia O
and O
may O
contribute O
to O
multiple O
established O
sex O
differences O
associated O
with O
the O
disorder O
. O

Here O
we O
examined O
sex-dependent O
hormone O
associations O
with O
resting O
brain O
activity O
and O
their O
clinical O
associations O
in O
schizophrenia O
patients O
. O

Methods O
OT O
and O
AVP O
serum O
concentrations O
were O
assayed O
in O
35 O
individuals O
with O
schizophrenia O
( O
23 O
men O
) O
and O
60 O
controls O
( O
24 O
men O
) O
from O
the O
Chicago O
BSNIP O
study O
site O
. O

Regional O
cerebral O
function O
was O
assessed O
with O
resting O
state O
fMRI O
by O
measuring O
the O
amplitude O
of O
low-frequency O
fluctuations O
( O
ALFF O
) O
which O
are O
believed O
to O
reflect O
intrinsic O
spontaneous O
neuronal O
activity O
. O

Results O
In O
female O
patients O
, O
lower O
OT O
levels O
were O
associated O
with O
lower O
ALFF O
in O
frontal O
and O
cerebellar O
cortices O
( O
p O
’ O
s O
< O
0.05 O
) O
and O
in O
female O
controls O
AVP O
levels O
were O
inversely O
associated O
with O
ALFF O
in O
the O
frontal O
cortex O
( O
p=0.01 O
) O
. O

In O
male O
patients O
, O
lower O
OT O
levels O
were O
associated O
with O
lower O
ALFF O
in O
the O
posterior O
cingulate O
and O
lower O
AVP O
levels O
were O
associated O
with O
lower O
ALFF O
in O
frontal O
cortex O
( O
p O
’ O
s O
< O
0.05 O
) O
. O

In O
male O
controls O
, O
lower O
OT O
levels O
were O
associated O
with O
lower O
ALFF O
in O
frontal O
cortex O
and O
higher O
ALFF O
in O
the O
thalamus O
( O
p O
’ O
s O
< O
0.05 O
) O
. O

There O
were O
some O
inverse O
ALFF-behavior O
associations O
in O
patients O
. O

Conclusions O
Alterations O
in O
peripheral O
hormone O
levels O
are O
associated O
with O
resting O
brain O
physiology O
in O
a O
sex-dependent O
manner O
in O
schizophrenia O
. O

These O
effects O
may O
contribute O
to O
sex O
differences O
in O
psychiatric O
symptom O
severity O
and O
course O
of O
illness O
in O
schizophrenia O
. O

2 O
. O

Methods O
2.1 O
. O

Participants O
Participants O
included O
35 O
individuals O
with O
DSM-IV O
diagnoses O
of O
schizophrenia O
( O
12 O
women O
, O
23 O
men O
) O
and O
60 O
healthy O
individuals O
( O
36 O
women O
, O
24 O
men O
) O
from O
the O
Chicago O
site O
of O
the O
Bipolar O
and O
Schizophrenia O
Network O
on O
Intermediate O
Phenotypes O
( O
B-SNIP O
) O
consortium O
at O
which O
plasma O
for O
endocrine O
assays O
was O
obtained O
. O

Recruitment O
, O
diagnostic O
strategies O
and O
patient O
characteristics O
have O
been O
described O
previously O
( O
Table O
1 O
) O
. O

All O
participants O
provided O
written O
informed O
consent O
and O
the O
study O
was O
approved O
by O
the O
University O
of O
Illinois O
at O
Chicago O
Institutional O
Review O
Board O
. O

A O
diagnosis O
of O
schizophrenia O
was O
made O
at O
consensus O
meetings O
using O
all O
available O
information O
including O
findings O
from O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
Axis O
I O
Disorders O
( O
SCID O
) O
. O

Healthy O
comparison O
subjects O
had O
no O
history O
of O
a O
psychotic O
disorder O
or O
recurrent O
depression O
, O
and O
no O
known O
immediate O
family O
history O
of O
these O
disorders O
. O

Exclusion O
criteria O
for O
all O
participants O
included O
: O
history O
of O
head O
injury O
with O
loss O
of O
consciousness O
> O
10 O
minutes O
; O
pregnancy O
; O
positive O
urine O
toxicology O
screen O
for O
common O
drugs O
of O
abuse O
on O
the O
day O
of O
testing O
; O
diagnosis O
of O
substance O
abuse O
in O
the O
past O
30 O
days O
or O
substance O
dependence O
in O
the O
past O
6 O
months O
; O
history O
of O
systemic O
medical O
or O
neurological O
disorder O
affecting O
mood O
or O
cognition O
; O
or O
age-corrected O
Wide-Range O
Achievement O
Test O
reading O
test O
standard O
score O
≤70 O
. O

2.2 O
Serum O
hormone O
assays O
Blood O
samples O
were O
drawn O
in O
the O
morning O
when O
possible O
( O
97 O
% O
blood O
draws O
before O
noon O
) O
. O

Samples O
were O
stored O
in O
plain O
tubes O
, O
spun O
at O
4°C O
, O
divided O
into O
aliquots O
( O
300ul O
) O
, O
and O
stored O
at O
−80°C O
. O

Samples O
were O
batched O
, O
diluted O
in O
an O
assay O
buffer O
to O
give O
reliable O
results O
within O
the O
linear O
portion O
of O
the O
standard O
curve O
( O
OT O
1:4 O
; O
AVP O
1:2 O
) O
, O
and O
completed O
in O
duplicate O
using O
unextracted O
plasma O
. O

EIA O
kits O
( O
Enzo O
Life O
Sciences/Assay O
Designs O
) O
were O
used O
to O
quantify O
OT O
and O
AVP O
and O
both O
hormones O
were O
assayed O
simultaneously O
. O

Samples O
were O
not O
extracted O
prior O
to O
performing O
the O
EIA O
as O
studies O
using O
mass O
spectrometry O
demonstrate O
high O
levels O
of O
OT O
in O
plasma O
and O
serum O
and O
indicate O
that O
methods O
involving O
extraction O
of O
samples O
removes O
much O
of O
this O
peptide O
. O

These O
EIAs O
are O
highly O
sensitive O
( O
minimal O
detection O
levels O
< O
12 O
pg/ml O
OT O
; O
4 O
pg/ml O
AVP O
) O
and O
cross-reactivity O
between O
OT O
and O
AVP O
is O
low O
( O
< O
0.04 O
% O
) O
. O

All O
OT O
values O
> O
2000 O
pg/ml O
and O
AVP O
values O
> O
400 O
pg/ml O
were O
re-run O
to O
confirm O
sample O
accuracy O
. O

This O
was O
only O
the O
case O
for O
OT O
level O
; O
no O
cases O
had O
AVP O
values O
> O
400pg/ml O
. O

For O
both O
assays O
, O
intra-assay O
coefficients O
of O
variation O
were O
< O
10.7 O
% O
. O

Hormone O
values O
were O
log O
transformed O
for O
statistical O
analysis O
. O

Mean O
daily O
chlorpromazine O
equivalent O
in O
patients O
was O
not O
associated O
with O
OT O
( O
r=−0.21 O
, O
p=0.33 O
) O
or O
AVP O
levels O
( O
r=−0.07 O
, O
p=0.74 O
) O
. O

Age O
was O
associated O
with O
OT O
( O
r=0.23 O
, O
p=0.03 O
) O
, O
but O
not O
AVP O
levels O
( O
r=0.13 O
, O
p=0.23 O
) O
. O

2.3 O
. O

Emotion O
processing O
and O
cognition O
From O
the O
Brief O
Assessment O
of O
Cognition O
in O
Schizophrenia O
( O
BACS O
) O
neuropsychological O
test O
battery O
, O
we O
selected O
three O
subtests O
including O
verbal O
learning O
( O
list O
learning O
) O
, O
verbal O
fluency O
( O
word O
generation O
) O
, O
and O
processing O
speed O
( O
symbol-coding O
) O
. O

The O
Penn O
Emotion O
Recognition O
( O
ER O
) O
-40 O
Test O
assessed O
the O
ability O
to O
accurately O
recognize O
facial O
emotions O
. O

These O
tests O
were O
selected O
based O
on O
previous O
research O
indicating O
that O
the O
tests O
demonstrate O
sex O
differences O
in O
the O
general O
population O
or O
if O
tests O
( O
verbal O
learning O
, O
processing O
speed O
) O
showed O
a O
sex O
difference O
in O
favor O
of O
women O
( O
p O
’ O
s O
< O
0.01 O
) O
in O
the O
large O
sample O
of O
healthy O
controls O
from O
the O
Bipolar O
and O
Schizophrenia O
Network O
on O
Intermediate O
Phenotypes O
study O
( O
N=304 O
, O
55 O
% O
women O
) O
. O

2.4 O
. O

Resting O
State O
Data O
Acquisition O
Participants O
underwent O
5 O
minutes O
of O
scanning O
using O
a O
GE O
Signa O
EXCITE O
3.0 O
Tesla O
MR O
imaging O
system O
and O
an O
8-channel O
phased O
array O
head O
coil O
. O

Participants O
fixated O
on O
a O
central O
crosshair O
for O
the O
duration O
of O
the O
scan O
. O

Video O
monitoring O
of O
participants O
eyes O
confirmed O
adherence O
to O
this O
instruction O
. O

Soft O
ear O
plugs O
were O
used O
to O
reduce O
scan O
noise O
, O
and O
head O
motion O
was O
minimized O
with O
head O
cushions O
. O

Echo-planar O
imaging O
sensitive O
to O
changes O
in O
BOLD O
signals O
( O
repetition O
time= O
1775msec O
, O
echo O
time= O
27msec O
, O
flip O
angle= O
60° O
) O
were O
obtained O
. O

The O
slice O
thickness O
was O
4 O
mm O
( O
1mm O
gap O
) O
with O
a O
matrix O
size O
of O
64×64 O
and O
a O
field O
of O
view O
of O
220×220 O
mm2 O
, O
resulting O
in O
a O
voxel O
size O
of O
3.44×3.44×5 O
mm3 O
. O

Each O
brain O
volume O
was O
comprised O
of O
29 O
axial O
slices O
, O
and O
each O
functional O
run O
contained O
210 O
image O
volumes O
. O

2.5 O
. O

Data O
Processing O
The O
first O
5 O
volumes O
were O
discarded O
to O
achieve O
steady-state O
longitudinal O
magnetization O
. O

Remaining O
data O
were O
preprocessed O
by O
Data O
Processing O
Assistant O
for O
Resting-State O
fMRI O
, O
version O
2.3 O
( O
http O
: O
//rfmri.org/DPARSF O
) O
software O
, O
implemented O
within O
the O
MATLAB O
toolbox O
, O
including O
slice O
timing O
and O
head O
motion O
correction O
, O
spatial O
normalization O
, O
and O
smoothing O
with O
a O
Gaussian O
kernel O
of O
6 O
mm3 O
full O
width O
at O
half O
maximum O
. O

fMRI O
images O
were O
spatially O
normalized O
to O
Montreal O
Neurological O
Institute O
space O
using O
the O
standard O
echo-planar O
imaging O
template O
after O
resampling O
the O
images O
to O
achieve O
a O
voxel O
resolution O
of O
3×3×3 O
mm O
. O

The O
measurement O
of O
ALFF O
ranged O
from O
0.01 O
to O
0.08 O
Hz O
, O
which O
is O
believed O
to O
reflect O
regional O
spontaneous O
neural O
activity O
. O

To O
achieve O
this O
, O
we O
set O
the O
bandpass O
filtering O
range O
as O
0.01–0.08 O
HZ O
and O
removed O
the O
linear O
trend O
. O

Then O
, O
using O
fast O
Fourier O
transformation O
( O
parameters O
: O
taper O
percentage=0 O
, O
fast O
Fourier O
transform O
length O
=shortest O
) O
, O
we O
transformed O
the O
time O
series O
to O
the O
frequency O
domain O
, O
and O
obtained O
the O
power O
spectrum O
. O

Next O
, O
power O
was O
square O
root O
transformed O
and O
then O
averaged O
across O
0.01–0.08 O
Hz O
to O
yield O
a O
measure O
of O
the O
ALFF O
from O
each O
voxel O
. O

Finally O
, O
the O
ALFF O
of O
each O
voxel O
was O
then O
divided O
by O
the O
global O
mean O
ALFF O
value O
of O
the O
individual O
to O
standardize O
data O
across O
subjects O
. O

2.6 O
. O

Statistical O
Analyses O
All O
statistical O
analytic O
processes O
were O
performed O
in O
REST O
software O
( O
Resting-State O
fMRI O
Data O
Analysis O
Toolkit O
V1.8 O
; O
http O
: O
//restfmri.net/forum/rest O
) O
. O

First O
, O
we O
calculated O
the O
voxel-wise O
correlations O
between O
ALFF O
and O
hormone O
data O
within O
the O
patient O
and O
control O
groups O
respectively O
, O
and O
within O
male O
and O
female O
participants O
in O
each O
group O
, O
with O
age O
treated O
as O
a O
covariate O
. O

To O
detect O
differences O
in O
hormone-brain O
activity O
correlations O
between O
groups O
, O
voxel-based O
comparison O
of O
correlation O
maps O
was O
performed O
in O
SPM8 O
( O
http O
: O
//www.fil.ion.ecl.ac.uk/spm O
) O
. O

Primary O
analyses O
compared O
male O
patients O
and O
controls O
, O
and O
female O
patients O
and O
controls O
. O

The O
average O
correlation O
coefficient O
of O
brain O
regions O
( O
clusters O
of O
voxels O
) O
showing O
significant O
differences O
in O
hormone O
– O
brain O
physiology O
correlations O
were O
extracted O
, O
compared O
across O
groups O
, O
and O
correlated O
with O
clinical O
and O
demographic O
characteristics O
using O
cocor O
software O
( O
comparing O
correlations O
; O
http O
: O
//comparingcorrelations.org O
) O
. O

Primary O
correlational O
analyses O
investigated O
relations O
between O
hormones O
and O
brain O
physiology O
, O
and O
between O
brain O
physiology O
and O
behavior O
. O

A O
series O
of O
multivariable O
linear O
regressions O
were O
then O
conducted O
to O
determine O
whether O
brain O
physiology O
mediated O
hormone-behavior O
associations O
. O

In O
all O
image O
analyses O
, O
we O
used O
Monte O
Carlo O
simulations O
and O
AlphSim O
software O
to O
correct O
for O
multiple O
comparisons O
when O
testing O
for O
statistical O
significance O
. O

The O
probability O
of O
a O
false-positive O
detection O
for O
the O
study O
was O
set O
to O
p O
< O
0.05 O
using O
a O
minimum O
cluster O
size O
of O
5 O
contiguous O
voxels O
significant O
individually O
at O
a O
threshold O
of O
p O
< O
0.05 O
( O
http O
: O
//afni.nimh.nih.gov/pub/dist/doc/manual/AlphaSim.pdf O
) O
. O

The O
AlphSim O
calculation O
was O
conducted O
using O
REST O
software O
( O
http O
: O
//restfmri.net/forum/index.php O
) O
, O
which O
integrated O
the O
true O
smoothness O
kernel O
estimated O
based O
on O
the O
statistical O
map O
and O
mask O
file O
. O

